Evoke Pharma Files 8-K on Shareholder Votes and Financials
| Field | Detail |
|---|---|
| Company | Evoke Pharma Inc |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
Related Tickers: EVOK
TL;DR
Evoke Pharma (EVOK) filed an 8-K on 5/21 for shareholder votes & financials.
AI Summary
Evoke Pharma Inc. filed an 8-K on May 21, 2025, reporting on the submission of matters to a vote of security holders and financial statements. The company, incorporated in Delaware with its principal executive offices in Solana Beach, California, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing indicates important corporate actions and financial reporting by Evoke Pharma, which could impact investors' understanding of the company's governance and financial health.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Numbers
- 001-36075 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20-8447886 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Evoke Pharma Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Solana Beach, California (location) — Principal Executive Offices
- May 21, 2025 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Evoke Pharma Inc.?
Evoke Pharma Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 21, 2025.
Where are Evoke Pharma's principal executive offices located?
Evoke Pharma's principal executive offices are located at 420 Stevens Avenue, Suite 230, Solana Beach, California 92075.
What is the company's fiscal year end?
The company's fiscal year ends on December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Evoke Pharma Inc.